Green Nut Oil or DHA Supplementation Restored Decreased Distribution Levels of DHA Containing Phosphatidylcholines in the Brain of a Mouse Model of Dementia.
Ariful IslamEmiko TakeyamaMd Al MamunTomohito SatoMakoto HorikawaYutaka TakahashiKenji KikushimaMitsutoshi SetouPublished in: Metabolites (2020)
Dementia is a major public health concern nowadays. Reduced levels of brain docosahexaenoic acid (DHA) and DHA-phosphatidylcholines (DHA-PCs) in dementia patients were reported previously. Recently, we have reported that supplementation of green nut oil (GNO) or DHA improves memory function and distribution levels of brain DHA in senescence accelerated mice P8 (SAMP8). GNO is extracted from Plukenetia volubilis seeds, and SAMP8 is a well-known model mouse of dementia. In this current study, we examined the results of GNO or DHA supplementation in the distribution levels of brain DHA-PCs in same model mouse of dementia using desorption electrospray ionization (DESI) mass spectrometry imaging (MSI). We observed significantly decreased distribution of brain DHA-PCs, PC (16:0_22:6), and PC (18:0_22:6) in SAMP8 mice compared to wild type mice, and GNO or DHA treatment restored the decreased distribution levels of PC (16:0_22:6) and PC (18:0_22:6) in the brain of SAMP8 mice. These results indicate that GNO or DHA supplementation can ameliorate the decreased distribution of brain DHA-PCs in dementia, and could be potentially used for the prevention and treatment of dementia.
Keyphrases
- fatty acid
- mild cognitive impairment
- resting state
- white matter
- cognitive impairment
- public health
- wild type
- functional connectivity
- mouse model
- cerebral ischemia
- high fat diet induced
- high resolution
- end stage renal disease
- chronic kidney disease
- multiple sclerosis
- metabolic syndrome
- skeletal muscle
- oxidative stress
- insulin resistance
- adipose tissue
- blood brain barrier
- endothelial cells
- dna damage
- subarachnoid hemorrhage
- combination therapy
- fluorescence imaging
- smoking cessation